Takeda Pharmaceutical (TAK) EBIT (2017 - 2026)
Takeda Pharmaceutical's EBIT came in at $1.26 billion for the quarter ended Jun 30, 2026, down 0.9% from $1.28 billion a year earlier and down 1.6% from the prior quarter.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) EBIT (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Takeda Pharmaceutical reported EBIT of $2.71 billion, down 43.4% year-over-year; for the year ended Mar 31, 2026, it came in at $41.3 million, down 98.2% from the prior year.
- EBIT carries a five-year compound annual growth rate of -61.4% (years ended Mar 2021 to Mar 2026).
- Going back by year, EBIT was $2.25 billion in the year ended Mar 31, 2025 (+51.5%), $1.48 billion in the year ended Mar 31, 2024 (-59.1%), $3.63 billion in the year ended Mar 31, 2023 (-11.5%) and $4.1 billion in the year ended Mar 31, 2022 (-14.6%).
- The five-year range for quarterly EBIT is -$2.7 billion (the quarter ended Dec 31, 2025) to $2.87 billion (the quarter ended Sep 30, 2025).
- Year-over-year, EBIT increased in five of the last six quarters, with growth averaging 5.7%.
- The fastest year-over-year change in EBIT over five years came in the quarter ended Sep 30, 2023 (growth of 268.0%), and the weakest in the quarter ended Dec 31, 2023 (a decline of 42.4%).
- Business Quant data shows TAK's EBIT at $1.28 billion (quarter ended Mar 31, 2026), -$2.7 billion (quarter ended Dec 31, 2025) and $2.87 billion (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Takeda Pharmaceutical | 2.74 Bn | -23.77 Bn | 5.10 Bn | 1.26 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.26 Bn |
| Mar 31, 2026 | 1.28 Bn |
| Dec 31, 2025 | -2.70 Bn |
| Sep 30, 2025 | 2.87 Bn |
| Jun 30, 2025 | 1.28 Bn |
| Mar 31, 2025 | 1.21 Bn |
| Dec 31, 2024 | -492.68 Mn |
| Sep 30, 2024 | 2.80 Bn |
| Jun 30, 2024 | 1.07 Bn |
| Mar 31, 2024 | 1.14 Bn |
| Dec 31, 2023 | 599.40 Mn |
| Sep 30, 2023 | 2.78 Bn |
| Jun 30, 2023 | 1.23 Bn |
| Mar 31, 2023 | 1.27 Bn |
| Dec 31, 2022 | 1.04 Bn |
| Sep 30, 2022 | 756.19 Mn |
| Jun 30, 2022 | 1.16 Bn |
| Mar 31, 2022 | 2.14 Bn |
| Jun 30, 2021 | 2.27 Bn |
| Mar 31, 2021 | 2.35 Bn |
API Access
Takeda Pharmaceutical EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();